Biotage AB (BIOT) - Cash Flow Conversion Efficiency

Latest as of March 2025: 0.011x

Based on the latest financial reports, Biotage AB (BIOT) has a cash flow conversion efficiency ratio of 0.011x as of March 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr43.00 Million ≈ $4.63 Million USD) by net assets (Skr3.85 Billion ≈ $413.89 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See net asset quality index of Biotage AB to measure how much of total assets are equity-financed.

Biotage AB - Cash Flow Conversion Efficiency Trend (2002–2024)

This chart illustrates how Biotage AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Biotage AB cash earnings quality to evaluate the quality of earnings relative to operating cash generation.

Biotage AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Biotage AB ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Treehouse Foods Inc NYSE:THS	0.030x
Tekfen Holding AS IS:TKFEN	0.085x
CVR Partners LP NYSE:UAN	0.243x
Jinhui Liquor Co Ltd SHG:603919	-0.011x
Grupo Televisa S.A.B. F:TLV	0.100x
Techno Electric & Engineering Company Limited NSE:TECHNOE	-0.042x
Tourmaline Bio Inc. NASDAQ:TRML	-0.078x
COSMO Pharmaceuticals SA LSE:0RGI	0.002x

Annual Cash Flow Conversion Efficiency for Biotage AB (2002–2024)

The table below shows the annual cash flow conversion efficiency of Biotage AB from 2002 to 2024. For the full company profile with market capitalisation and key ratios, see Biotage AB market cap and net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Skr4.11 Billion ≈ $442.62 Million	Skr413.00 Million ≈ $44.45 Million	0.100x	+29.30%
2023-12-31	Skr3.66 Billion ≈ $393.55 Million	Skr284.00 Million ≈ $30.56 Million	0.078x	-62.72%
2022-12-31	Skr1.64 Billion ≈ $176.17 Million	Skr341.00 Million ≈ $36.70 Million	0.208x	-19.04%
2021-12-31	Skr1.37 Billion ≈ $147.65 Million	Skr353.00 Million ≈ $37.99 Million	0.257x	-8.72%
2020-12-31	Skr990.04 Million ≈ $106.54 Million	Skr279.05 Million ≈ $30.03 Million	0.282x	+16.50%
2019-12-31	Skr875.50 Million ≈ $94.22 Million	Skr211.81 Million ≈ $22.79 Million	0.242x	+9.59%
2018-12-31	Skr702.18 Million ≈ $75.57 Million	Skr155.00 Million ≈ $16.68 Million	0.221x	-20.47%
2017-12-31	Skr608.61 Million ≈ $65.50 Million	Skr168.93 Million ≈ $18.18 Million	0.278x	+12.42%
2016-12-31	Skr563.24 Million ≈ $60.61 Million	Skr139.07 Million ≈ $14.97 Million	0.247x	+12.41%
2015-12-31	Skr546.66 Million ≈ $58.83 Million	Skr120.08 Million ≈ $12.92 Million	0.220x	+36.47%
2014-12-31	Skr502.65 Million ≈ $54.09 Million	Skr80.91 Million ≈ $8.71 Million	0.161x	+35.21%
2013-12-31	Skr476.77 Million ≈ $51.31 Million	Skr56.76 Million ≈ $6.11 Million	0.119x	-15.15%
2012-12-31	Skr530.83 Million ≈ $57.13 Million	Skr74.47 Million ≈ $8.01 Million	0.140x	-27.45%
2011-12-31	Skr563.90 Million ≈ $60.68 Million	Skr109.05 Million ≈ $11.74 Million	0.193x	+90.70%
2010-12-31	Skr567.95 Million ≈ $61.12 Million	Skr57.59 Million ≈ $6.20 Million	0.101x	+204.67%
2009-12-31	Skr1.09 Billion ≈ $117.20 Million	Skr36.25 Million ≈ $3.90 Million	0.033x	-57.81%
2008-12-31	Skr1.12 Billion ≈ $121.05 Million	Skr88.74 Million ≈ $9.55 Million	0.079x	+86.31%
2007-12-31	Skr796.26 Million ≈ $85.69 Million	Skr33.72 Million ≈ $3.63 Million	0.042x	-24.40%
2006-12-31	Skr712.47 Million ≈ $76.67 Million	Skr39.91 Million ≈ $4.29 Million	0.056x	+303.79%
2005-12-31	Skr738.25 Million ≈ $79.45 Million	Skr-20.29 Million ≈ $-2.18 Million	-0.027x	+85.31%
2004-12-31	Skr523.13 Million ≈ $56.30 Million	Skr-97.89 Million ≈ $-10.53 Million	-0.187x	-13.75%
2003-12-31	Skr609.50 Million ≈ $65.59 Million	Skr-100.27 Million ≈ $-10.79 Million	-0.165x	+20.20%
2002-12-31	Skr616.16 Million ≈ $66.31 Million	Skr-127.02 Million ≈ $-13.67 Million	-0.206x	--

About Biotage AB

ST:BIOT Sweden Medical Instruments & Supplies

Market Cap

$1.23 Billion

Skr11.46 Billion SEK

Market Cap Rank

#7891 Global

#120 in Sweden

Share Price

Skr143.20

Change (1 day)

+0.00%

52-Week Range

Skr143.20 - Skr143.20

All Time High

Skr280.87